<DOC>
	<DOCNO>NCT00639483</DOCNO>
	<brief_summary>To assess efficacy safety celecoxib add-on therapy risperidone versus risperidone alone patient schizophrenia</brief_summary>
	<brief_title>Efficacy Safety Celecoxib Add-on Therapy Risperidone Versus Risperidone Alone Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Inclusion criterion : Diagnosis schizophrenia ( accord Diagnostic Statistical Manual Mental Disorders [ DSM ] IVTR criterion make specialist psychiatry ) acute exacerbation schizophrenia require hospitalization Total PANSS score ? 60 screen History schizophrenia ? 10 year ( onset prodromal symptom ) Exclusion criterion : AxisI DSMIVTR diagnosis schizophrenia Less full cycle lapse time screen follow last injection depot antipsychotic Currently take celecoxib selective cyclooxygenase 2 inhibitor , antiinflammatory medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>